The Marcus (MCS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Second quarter 2024 revenue declined 15% year-over-year to $176 million, with hotels outperforming and theaters rebounding in June as film supply improved.
Net loss for Q2 was $20.2 million, impacted by $15 million in debt conversion expense; excluding this, net loss was $5.2 million.
Adjusted EBITDA fell 43.3% in Q2 to $22 million, reflecting lower theater attendance and debt conversion expense.
Financial highlights
Q2 2024 revenues: $176 million (down from $207 million in Q2 2023); first half revenues: $314.6 million (down from $359.3 million).
Q2 operating income: $2.2 million (down from $20.8 million); first half operating loss: $14.4 million.
Net loss per diluted share: $(0.64) in Q2 (or $0.17 excluding debt conversion expense); first half net loss per share: $1.03 (or $0.56 adjusted).
Adjusted EBITDA: $22 million in Q2 (down from $38.7 million); $24.3 million for the first half (down from $48.2 million).
Cash and equivalents at June 27, 2024: $32.8 million; $175.2 million available under $225 million revolving credit facility.
Outlook and guidance
Hotels expected to continue strong group bookings, with group pace for 2024 up 11% and for 2025 up 36% year-over-year.
Theaters anticipate a stronger second half as film supply normalizes, with a robust slate for late 2024 and 2025.
Effective tax rate for 2024 expected in the 5-10% range, excluding one-time items.
Capital expenditures for 2024 projected at $60–$75 million.
Latest events from The Marcus
- Revenue grew 3.8% as both divisions outperformed, with improved losses and strong cash flow.MCS
Q1 202621 Jul 2026 - Q1 revenue up 7.4% to $148.8M, but net loss widened to $16.8M on higher costs.MCS
Q1 20259 Jul 2026 - Board, compensation, and auditor votes passed overwhelmingly; no Q&A from shareholders.MCS
AGM 202621 May 2026 - Both divisions outperformed peers in 2025, with strong revenue growth and a robust 2026 outlook.MCS
Q4 20258 Apr 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.MCS
Proxy filing7 Apr 2026 - Virtual annual meeting to vote on directors, pay, and auditor ratification, all board-backed.MCS
Proxy filing7 Apr 2026 - 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025